ACIU
Price
$2.21
Change
+$0.17 (+8.33%)
Updated
Sep 2, 04:04 PM (EDT)
Capitalization
205.22M
73 days until earnings call
VANI
Price
$1.17
Change
+$0.02 (+1.74%)
Updated
Sep 2, 03:40 PM (EDT)
Capitalization
68.13M
77 days until earnings call
Interact to see
Advertisement

ACIU vs VANI

Header iconACIU vs VANI Comparison
Open Charts ACIU vs VANIBanner chart's image
AC Immune SA
Price$2.21
Change+$0.17 (+8.33%)
Volume$100
Capitalization205.22M
Vivani Medical
Price$1.17
Change+$0.02 (+1.74%)
Volume$590
Capitalization68.13M
ACIU vs VANI Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. VANI commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and VANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (ACIU: $2.04 vs. VANI: $1.15)
Brand notoriety: ACIU and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 93% vs. VANI: 58%
Market capitalization -- ACIU: $205.22M vs. VANI: $68.13M
ACIU [@Biotechnology] is valued at $205.22M. VANI’s [@Biotechnology] market capitalization is $68.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 2 TA indicator(s) are bullish while VANI’s TA Score has 3 bullish TA indicator(s).

  • ACIU’s TA Score: 2 bullish, 7 bearish.
  • VANI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, VANI is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а -5.12% price change this week, while VANI (@Biotechnology) price change was -7.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.60%. For the same industry, the average monthly price growth was +22.12%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

ACIU is expected to report earnings on Nov 14, 2025.

VANI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($205M) has a higher market cap than VANI($68.1M). VANI YTD gains are higher at: -0.862 vs. ACIU (-24.444). VANI has higher annual earnings (EBITDA): -26.38M vs. ACIU (-48.05M). ACIU has more cash in the bank: 127M vs. VANI (6.79M). ACIU has less debt than VANI: ACIU (4.92M) vs VANI (18.6M). ACIU has higher revenues than VANI: ACIU (28.9M) vs VANI (0).
ACIUVANIACIU / VANI
Capitalization205M68.1M301%
EBITDA-48.05M-26.38M182%
Gain YTD-24.444-0.8622,836%
P/E RatioN/AN/A-
Revenue28.9M0-
Total Cash127M6.79M1,869%
Total Debt4.92M18.6M26%
FUNDAMENTALS RATINGS
ACIU vs VANI: Fundamental Ratings
ACIU
VANI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
9037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (46) in the Pharmaceuticals Major industry is in the same range as VANI (67) in the null industry. This means that ACIU’s stock grew similarly to VANI’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that ACIU’s stock grew similarly to VANI’s over the last 12 months.

ACIU's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that ACIU’s stock grew similarly to VANI’s over the last 12 months.

ACIU's Price Growth Rating (62) in the Pharmaceuticals Major industry is in the same range as VANI (64) in the null industry. This means that ACIU’s stock grew similarly to VANI’s over the last 12 months.

ACIU's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that ACIU’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUVANI
RSI
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
77%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 6 days ago
75%
MACD
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 6 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
83%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
88%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAPGF0.94N/A
N/A
Mapletree Logistics Trust Units Real Estate Investment Trust
MLYBY4.47N/A
N/A
Malayan Banking Berhad
TGLDF0.10N/A
N/A
RENEGADE GOLD INC.
IPHLF4.42N/A
N/A
IPH LTD.
HAIAF11.72N/A
N/A
Healthcare AI Acquisition Corp.

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-0.49%
RGNX - ACIU
41%
Loosely correlated
-0.89%
TECH - ACIU
39%
Loosely correlated
+0.55%
IRON - ACIU
39%
Loosely correlated
-0.03%
ARCT - ACIU
38%
Loosely correlated
-1.68%
SYRE - ACIU
38%
Loosely correlated
-1.38%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
-2.54%
VTVT - VANI
59%
Loosely correlated
N/A
ENVB - VANI
41%
Loosely correlated
-10.32%
GLSI - VANI
32%
Poorly correlated
+0.17%
KYTX - VANI
32%
Poorly correlated
+0.27%
ACIU - VANI
31%
Poorly correlated
-0.49%
More